Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Rabacfosadine is dosed at 1 mg/kg IV q3 weeks for 5 doses in dogs, per TANOVEA - Rabacfosadine Succinate Injection, Powder, for Solution [US Product Label for Dogs].; 2021. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b36e345-fae9-40ea-a069-6fefba92a89f — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1135 (2026-08-01). — Plumb's 10th ed (held) printed p.1108, Rabacfosadine monograph spanning p.1107-1108; page located 2026-08-05 from the book's own running heads, and carries this exact dose under the matching species heading. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207. Rabacfosadine is used in dogs for Canine lymphoma. Routes documented in dogs: IV. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Rabacfosadine in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Tanovea-CA1
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| IV | 1 mg/kg | q3 weeks for 5 doses | 5 treatments total | Canine lymphoma | Moderate | TANOVEA - Rabacfosadine Succinate Injection, Powder, for Solution [US Product Label for Dogs].; 2021. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b36e345-fae9-40ea-a069-6fefba92a89f — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1135 (2026-08-01). — Plumb's 10th ed (held) printed p.1108, Rabacfosadine monograph spanning p.1107-1108; page located 2026-08-05 from the book's own running heads, and carries this exact dose under the matching species heading. — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
Every held source for this drug and species, as printed. Where they differ, both are shown — the choice is yours, not ours.
| Dose (mg/kg) | Route | Source | As printed |
|---|---|---|---|
| 0.82–1 | IV | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.372 | 0.82-1 mg/kg i.v. over 30 min once every 21 days. Has been used in combination with doxorubicin |
Figures are transcribed from the cited page or table of each held edition and are shown for reference only. They are not dose recommendations, they do not feed the calculator, and none has been reviewed by a veterinarian.
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Prodrug that releases PMEG (a purine nucleotide analog) intracellularly, inhibiting DNA synthesis in rapidly dividing lymphoid cells.
Dogs only. Delayed pulmonary fibrosis (potentially fatal). Dermatologic toxicity. Monitor CBC. Conditionally approved for canine lymphoma.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Rabacfosadine dose range in dogs, with cited source references: IV 1 mg/kg q3 weeks for 5 doses. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Rabacfosadine in dogs: IV.
Cited course lengths for Rabacfosadine in dogs include: 5 treatments total. Duration depends on the indication — match it to the specific dose rule in the table above.
Rabacfosadine is indicated in dogs for: Canine lymphoma.
These are general warnings for Rabacfosadine across species; consult the dog dosing table above for species-specific guidance. Dogs only. Delayed pulmonary fibrosis (potentially fatal). Dermatologic toxicity. Monitor CBC. Conditionally approved for canine lymphoma.
Why a species-specific page? Rabacfosadine pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.